Sai Life Sciences, Centrix Pharma Solutions and Agility Life Sciences recently came together to host a webinar bringing together industry […]
Commercial-scale Photo Flow Chemistry successfully executed in Bidar
30 Apr 2026
Commercial-scale flow chemistry has been successfully executed at our API manufacturing site in Bidar for a late-phase program supporting a US-based innovator. This execution builds on prior investments in continuous processing infrastructure at the site, including a 3-litre photo flow reactor equipped with a monochromatic blue LED light source. The platform enables controlled photochemical transformations at kilogram scale and supports improved thermal management and reaction consistency compared to conventional batch processing.
Flow chemistry is applied where it offers clear advantages — particularly in the handling of hazardous intermediates, control of highly exothermic reactions, and management of light-driven transformations. Its integration into late-phase development and commercial manufacturing workflows supports safer scale-up and stronger process robustness.
The expansion strengthens our ability to incorporate continuous processing strategies into large-scale API programs where scientifically appropriate, supporting reliable execution through development and GMP manufacture.
Related News
Revenue up by 43%; EBITDA up by 79%; Net Profit up by 199% Hyderabad, February 05, 2026: Sai Life Sciences […]
6 Feb 2026
Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract Research, […]